Quest PharmaTech Inc. (QPTFF)
OTCMKTS · Delayed Price · Currency is USD
0.0133
-0.0017 (-11.33%)
At close: Jul 15, 2024
Quest PharmaTech Market Cap
Quest PharmaTech has a market cap or net worth of $3.73 million as of February 12, 2026. Its market cap has decreased by -0.08% in one year.
Market Cap
3.73M
Enterprise Value
4.43M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since June 18, 1999, Quest PharmaTech's market cap has decreased from 6.09M to 3.73M, a decrease of -38.65%. That is a compound annual growth rate of -1.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.73M | -13.69% |
| Dec 30, 2025 | 4.33M | 22.69% |
| Dec 30, 2024 | 3.53M | -49.98% |
| Dec 28, 2023 | 7.05M | -13.23% |
| Dec 30, 2022 | 8.12M | -35.69% |
| Dec 31, 2021 | 12.63M | -58.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GPL Holdings | 5.83M |
| Bioxytran | 5.56M |
| LakeShore Biopharma | 5.33M |
| Clearside Biomedical | 5.10M |
| AXIM Biotechnologies | 4.99M |
| Enzon Pharmaceuticals | 4.79M |
| Nymox Pharmaceutical | 4.23M |
| Vaccinex | 3.99M |